Repursposing the Kca3.1 Blocker Senicapoc as a Microglia-Targeted Therapeutic for Alzheimer's Disease

Biophysical Journal - United States
doi 10.1016/j.bpj.2018.11.1345
Full Text
Abstract

Available in full text

Categories
Biophysics
Date
Authors
Publisher

Elsevier BV

Related search

Vaccination as a Therapeutic Approach to Alzheimer's Disease

Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine
2010English

Derivatives of Piperazines as Potential Therapeutic Agents for Alzheimer's Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2019English

Targeted Therapies for Alzheimer's Disease: An Overview

2017English

Platinum-Based Inhibitors of Amyloid- As Therapeutic Agents for Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Therapeutic Perspectives in Alzheimer's Disease

Recent Patents on CNS Drug Discovery
PsychiatryDrug DiscoveryMental HealthPharmacology
2012English

Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?

Molecular Neurobiology
NeuroscienceNeurologyCellularMolecular Neuroscience
2010English

Can Small Molecule Inhibitors of Glutaminyl Cyclase Be Used as a Therapeutic for Alzheimer's Disease?

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2017English

Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2019English

KCa3.1 Ion Channel: A Novel Therapeutic Target for Corneal Fibrosis

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy